RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+13.11%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.29B
AUM Growth
+$2.29B
(+15%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
8.84%
Top 10 Holdings %
Top 10 Hldgs %
38.35%
Holding
106
New
18
Increased
27
Reduced
10
Closed
11
Top Buys
| 1 |
New Fortress Energy
NFE
|
$35.7M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$33.6M |
| 3 |
Xperi
XPER
|
$33.1M |
| 4 |
Roivant Sciences
ROIV
|
$24M |
| 5 |
Zymeworks
ZYME
|
$23.7M |
Top Sells
| 1 |
Adeia
ADEA
|
$94.3M |
| 2 |
Apollo Global Management
APO
|
$44.2M |
| 3 |
Green Plains
GPRE
|
$29.8M |
| 4 |
FerroAtlántica
GSM
|
$27.9M |
| 5 |
Hertz
HTZ
|
$16.6M |
Sector Composition
| 1 | Healthcare | 27.59% |
| 2 | Energy | 19.67% |
| 3 | Industrials | 18.24% |
| 4 | Technology | 7.41% |
| 5 | Financials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
FerroAtlántica
GSM
$774M
| $12.4M | 0.54% |
3,232,762
-7,255,939
| -69% | -$27.9M |
|
52
Cenovus Energy
CVE
$29.7B
| $11M | 0.48% |
+568,600
| New | +$11M |
|
53
Trevi Therapeutics
TRVI
$871M
| $11M | 0.48% |
5,684,420
| – | – |
|
54
Lantheus
LNTH
$3.75B
| $10.9M | 0.47% |
+213,207
| New | +$10.9M |
|
55
Telesat
TSAT
$307M
| $10.6M | 0.46% |
1,410,000
| – | – |
|
56
TherapeuticsMD
TXMD
$12.7M
| $9.82M | 0.43% |
1,757,191
+600,238
| +52% | +$3.36M |
|
57
FTAI Infrastructure
FIP
$479M
| $9.42M | 0.41% |
3,193,530
| – | – |
|
58
Semtech
SMTC
$5.03B
| $8.88M | 0.39% |
+309,347
| New | +$8.88M |
|
59
OmniAb
OABI
$219M
| $8.1M | 0.35% |
+2,249,222
| New | +$8.1M |
|
60
Arbutus Biopharma
ABUS
$753M
| $8.08M | 0.35% |
+3,466,281
| New | +$8.08M |
|
|
MREO
61
Mereo BioPharma
MREO
$275M
| $7.77M | 0.34% |
10,366,120
| – | – |
|
62
Nerdy
NRDY
$159M
| $7.76M | 0.34% |
3,450,406
| – | – |
|
63
PLAYSTUDIOS Inc
MYPS
$118M
| $7.61M | 0.33% |
1,961,184
| – | – |
|
64
Suncor Energy
SU
$49.3B
| $7.38M | 0.32% |
+232,558
| New | +$7.38M |
|
65
Krystal Biotech
KRYS
$4.35B
| $7.34M | 0.32% |
92,609
| – | – |
|
66
Cimpress
CMPR
$1.49B
| $7.16M | 0.31% |
+259,456
| New | +$7.16M |
|
67
Cullinan Oncology
CGEM
$456M
| $6.61M | 0.29% |
626,929
+67,192
| +12% | +$709K |
|
68
Laureate Education
LAUR
$4.12B
| $6.31M | 0.27% |
655,482
| – | – |
|
|
VNET
69
VNET Group
VNET
$2.15B
| $6.2M | 0.27% |
+1,093,893
| New | +$6.2M |
|
70
Cameco
CCJ
$33.6B
| $5.67M | 0.25% |
+250,000
| New | +$5.67M |
|
|
MORF
71
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.33M | 0.23% |
+199,264
| New | +$5.33M |
|
72
Ovintiv
OVV
$10.6B
| $5.02M | 0.22% |
+99,011
| New | +$5.02M |
|
|
NGM
73
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.4M | 0.19% |
877,161
| – | – |
|
74
Tarsus Pharmaceuticals
TARS
$2.44B
| $4.17M | 0.18% |
284,732
| – | – |
|
|
FREE
75
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $4.06M | 0.18% |
998,363
-2,585,000
| -72% | -$10.5M |
|